What Does Minimally Invasive Mitral Valve Surgery Really Mean? Defining Totally Endoscopic Mitral Valve Surgery Through Meta Analysis.

IF 0.8 Q4 SURGERY Surgical technology international Pub Date : 2023-12-15 DOI:10.52198/23.STI.43.CV1715
Jessica Katsiroubas, Emily Manin, Jake L Rosen, Yoona Choe, Idy Ding, Keertana Jonnalagadda, T Sloane Guy
{"title":"What Does Minimally Invasive Mitral Valve Surgery Really Mean? Defining Totally Endoscopic Mitral Valve Surgery Through Meta Analysis.","authors":"Jessica Katsiroubas, Emily Manin, Jake L Rosen, Yoona Choe, Idy Ding, Keertana Jonnalagadda, T Sloane Guy","doi":"10.52198/23.STI.43.CV1715","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Minimally invasive approaches to mitral valve surgery are being performed with increasing frequency; however, many of these procedures still involve rib spreading and large incisions. The heterogeneity of self-reported \"minimally invasive\" approaches limits analysis of outcomes. This review aims to formally define totally endoscopic mitral valve surgery (TEMVS) and assess outcomes.</p><p><strong>Materials and methods: </strong>A comprehensive literature search in Pub-Med, Cochrane Library, and EMBASE was used to find studies reporting outcomes on totally endoscopic mitral valve surgery. \"Totally endoscopic\" was defined as incisions less than 3cm and the avoidance of rib spreading. The primary outcome was 30-day mortality and secondary endpoints included postoperative myocardial infarction (MI), stroke, early reoperation, wound infection, renal failure, and prolonged ventilation. Perioperative patient characteristics were also recorded and analyzed.</p><p><strong>Results: </strong>Thirty-three studies (6031 patients) were included in our meta-analysis. The 30-day mortality rate was 0.33%, p=0.88. The most frequent complications were early reoperation (2.12%, p=0.44) and prolonged ventilation (1.46% p=<0.01). Rates of MI, stroke, and renal failure were each less than 1%. Patient characteristics including age, body mass index (BMI), and ejection fractions were also analyzed.</p><p><strong>Conclusions: </strong>We propose a formal definition of TEMVS, which is performed through incisions less than 3cm and without rib spreading. Thirty-day mortality and other adverse sequelae of TEMVS are uncommon.</p>","PeriodicalId":22194,"journal":{"name":"Surgical technology international","volume":null,"pages":null},"PeriodicalIF":0.8000,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical technology international","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52198/23.STI.43.CV1715","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Minimally invasive approaches to mitral valve surgery are being performed with increasing frequency; however, many of these procedures still involve rib spreading and large incisions. The heterogeneity of self-reported "minimally invasive" approaches limits analysis of outcomes. This review aims to formally define totally endoscopic mitral valve surgery (TEMVS) and assess outcomes.

Materials and methods: A comprehensive literature search in Pub-Med, Cochrane Library, and EMBASE was used to find studies reporting outcomes on totally endoscopic mitral valve surgery. "Totally endoscopic" was defined as incisions less than 3cm and the avoidance of rib spreading. The primary outcome was 30-day mortality and secondary endpoints included postoperative myocardial infarction (MI), stroke, early reoperation, wound infection, renal failure, and prolonged ventilation. Perioperative patient characteristics were also recorded and analyzed.

Results: Thirty-three studies (6031 patients) were included in our meta-analysis. The 30-day mortality rate was 0.33%, p=0.88. The most frequent complications were early reoperation (2.12%, p=0.44) and prolonged ventilation (1.46% p=<0.01). Rates of MI, stroke, and renal failure were each less than 1%. Patient characteristics including age, body mass index (BMI), and ejection fractions were also analyzed.

Conclusions: We propose a formal definition of TEMVS, which is performed through incisions less than 3cm and without rib spreading. Thirty-day mortality and other adverse sequelae of TEMVS are uncommon.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
微创二尖瓣手术到底意味着什么?通过荟萃分析定义全内窥镜二尖瓣手术。
引言:二尖瓣手术的微创方法越来越频繁;然而,这些手术中的许多仍然涉及肋骨扩张和大切口。自我报告的“微创”方法的异质性限制了对结果的分析。本综述旨在正式定义全内窥镜二尖瓣手术(TEMVS)并评估结果。材料和方法:在Pub-Med、Cochrane Library和EMBASE中进行全面的文献检索,以寻找报告全内窥镜二尖瓣手术结果的研究。“全内窥镜”的定义是切口小于3厘米,避免肋骨扩张。主要转归为30天死亡率,次要终点包括术后心肌梗死(MI)、中风、早期再手术、伤口感染、肾衰竭和长期通气。还记录和分析了围手术期患者的特征。结果:33项研究(6031名患者)纳入我们的荟萃分析。30天死亡率为0.33%,p=0.88。最常见的并发症是早期再次手术(2.12%,p=0.44)和延长通气时间(1.46%,p=结论:我们提出了TEVS的正式定义,即通过小于3cm的切口进行,并且没有肋骨扩张。TEVS的30天死亡率和其他不良后遗症并不常见。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
2.00
自引率
0.00%
发文量
141
期刊最新文献
Robotic Assisted Lapendoscopic Single-Site Surgery for Ileal Deep Endometriosis. A Case Report and Review of Literature. Robotic versus Laparoscopic Partial Nephrectomy: A Systematic Review and Meta-Analysis of Randomised Trials. Cardiophrenic Lymph Node Resection Through Abdominal Subxiphoid Approach: Surgical Technique. What Happens to Endometriosis During the Menstrual Cycle? Robotic Total Knee Arthroplasty is Associated with Thinner and Less Constrained Polyethylene Inserts.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1